Page 13 - Indian Pharma Companies
Charticle: How Jan Aushadhi stores are disrupting the Indian pharma market
Analysts point out that growth from product introductions has nearly halved over the last two years as the drug regulator has been more stringent about new combination drugs
 "Charticle: How Jan Aushadhi stores are disrupting the Indian pharma market")
Jan Aushadhi scheme may disrupt 20% of Indian pharma market sales: Report
India has over 5,000 Jan Aushadhi stores that cover a list of 800 plus drugs, both chronic and acute
 "Jan Aushadhi scheme may disrupt 20% of Indian pharma market sales: Report")
Cold wave across US to bring big business for Indian drug companies
There have been 20.4 million to 23.6 million flu illnesses in the US between October 1, 2018, and February 23, 2019
Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL
As per Crisil, green shoots are already visible in the first quarter for 20 of these listed drug-makers
 "Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL")
Warning letters to Indian pharma companies from US FDA declining: Study
The number of cases of data integrity violations too is showing a decline, says study by IPA and consultancy firm McKinsey
 "Warning letters to Indian pharma companies from US FDA declining: Study")
Indian pharma sees traction in novel biologics
While Glenmark is betting on its biologic for atorpic dermatitis, Biocon was the first to develop and introduce two novel biologics in the Indian market
 "Indian pharma sees traction in novel biologics")
Competition takes shine off niche pharma products
Aurobindo has been able to partially buck the trend; analysts expect prospects of most players to improve in second half of FY19
 "Competition takes shine off niche pharma products")